paclitaxel has been researched along with Glial Cell Tumors in 176 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.57) | 18.7374 |
| 1990's | 21 (11.93) | 18.2507 |
| 2000's | 45 (25.57) | 29.6817 |
| 2010's | 86 (48.86) | 24.3611 |
| 2020's | 23 (13.07) | 2.80 |
| Authors | Studies |
|---|---|
| Barrows, LR; Ireland, CM; Kokoshka, JM | 1 |
| Harhaji, L; Isakovic, A; Jankovic, T; Kostic-Rajacic, S; Nikolic, Z; Trajkovic, V; Vajs, V | 1 |
| Chang, LC; Chen, CH; Chen, Y; Choi, J; Hilliard, TS; Kawakami, JK; Li, Y; Miklossy, G; Paladino, D; Sarkaria, JN; Sun, D; Turkson, J; Wongwiwatthananukit, S; Youn, UJ; Yue, P; Zhang, M | 1 |
| Dai, Z; Huang, WY; Khan, A; Liu, YP; Luo, XD; Wang, XH; Wang, YF; Wei, X; Yang, J; Yang, ZF; Yu, HF; Zhao, XD; Zhao, YL | 1 |
| Gangjee, A; Hamel, E; Ihnat, MA; Luckett-Chastain, LR; Mooberry, SL; Quadery, TM; Xiang, W | 1 |
| Chen, LQ; Duan, HX; Gao, ZG; Han, Y; Huang, W; Jin, MJ; Liu, W; Qi, LL; Wang, QM; Xin, X; Zhang, XT; Zhang, YY; Zhang, ZA | 1 |
| Chen, LQ; Duan, HX; Gao, ZG; Huang, W; Jin, MJ; Liu, C; Liu, YH; Qi, LL; Xin, X; Zhang, YY; Zhang, ZA; Zhao, HM | 1 |
| Chen, W; Di, Q; Quan, J; Sun, P; Tang, H; Wang, Q; Wu, H; Wu, Z; Xiao, Y; Zhao, X | 1 |
| Fan, JZ; Jia, LC; Lu, YN; Lv, YY; Sun, XY; Wang, XL; Zeng, LH; Zhao, WZ | 1 |
| Cao, M; Duan, X; Huang, S; Jiang, S; Li, X; Mao, J; Shen, J; Zhang, F; Zhang, X | 1 |
| Cao, X; Chen, W; He, W; Li, S; Lu, H; Lv, L; Lv, W; Min, Z; Sun, S; Teng, C; Wang, X; Xin, H; Ye, L; Yin, H; Zhang, Q | 1 |
| Chen, J; Hai, L; Liu, Q; Lu, R; Wang, S; Wu, Y; Yang, C; Yang, Z | 1 |
| Banerjee, R; Chaudhari, P; Chekuri, G; Dutt, S; Gera, P; Goda, J; Mohanty, B; Sandbhor, P; Yadav, S | 1 |
| Geetha, KM; Murugan, V; Vishwanath, K; Wilson, B | 1 |
| Szymaszek, Ż; Twardowska, M; Uram, Ł; Walczak, M; Wołowiec, S; Wróbel, K | 1 |
| Arrieta, VA; Baran, A; Canney, M; Carpentier, A; Chen, L; Desseaux, C; Dmello, C; Gonzalez-Buendia, E; Horbinski, C; James, CD; Kane, JR; Magnusson, LP; Muzzio, M; Sonabend, AM; Stupp, R; Zhang, DY | 1 |
| Fu, Y; Guo, C; Huang, S; Li, L; Lin, Q; Liu, W; Wang, L; Zhang, L; Zhang, Z | 1 |
| Chai, Z; Li, J; Lu, L; Lu, W; Mao, J; Ran, D; Wu, S; Xie, C; Zhan, C; Zhang, Y; Zhou, J | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Hu, F; Wang, K; Wen, C; Wen, L; Yuan, H; Zhang, F | 1 |
| Duan, X; Li, Q; Li, X; Li, Y; Shi, L; Wang, Y | 1 |
| Alam, MK; Lee, Y; Sidu, RK; Thakur, A; Yang, M; Zou, H | 1 |
| Chen, X; Li, F; Piao, JG; Wei, Y; Wu, F; Zhang, K; Zhang, Y; Zheng, H; Zhu, J; Zhu, Z | 1 |
| Hai, L; Liu, Q; Lu, R; Wang, S; Wu, Y; Yang, C; Zhou, L | 1 |
| Gao, C; Hong, C; Kim, J; Li, S; Liang, J; Ren, H; Wang, A; Wang, J; Wang, Q; Xia, J; Zhang, F; Zhong, Z; Zhu, Y; Zuo, Z | 1 |
| Chen, X; Hu, F; Liu, X; Xu, B; Zhang, Q; Zuo, Y | 1 |
| Chen, Z; Li, X; Ma, M; Tang, XL; Wang, Z | 1 |
| Jiao, Y; Li, SA; Liu, XY; Luo, WZ; Lv, CY; Sun, HW; Wang, JK; Wang, M; Wang, ZM; Zhang, P; Zhao, PC; Zhao, Y | 1 |
| Lu, W; Mao, J; Ran, D; Shen, Q; Wang, R; Xie, C; Zhan, C | 1 |
| Chen, XZ; Cheng, H; Huang, H; Qin, W; Tang, J; Wang, Y; Xiong, H; Yang, J; Zhang, Y; Zhou, C | 1 |
| Hao, X; Xin, S; Yang, C; Yu, F | 1 |
| Lu, W; Lu, WL; Mao, J; Ran, D; Ruan, H; Xie, C; Ying, M; Zhan, C; Zhou, J | 1 |
| Chen, J; Ding, L; Duan, Y; Huang, C; Li, R; Shen, M; Sun, Y; Wang, Q; Zhang, X | 1 |
| Chen, T; Fu, Y; Gong, T; Liu, X; Zhang, Z; Zhao, T | 1 |
| Kong, L; Mo, R; Ping, Q; Shen, S; Sun, H; Wang, L; Wei, Z; Wen, Y; Xue, J; Xue, L; Zhang, C; Zhang, L; Zhao, Z | 1 |
| Alessandri, G; Aralla, M; Bonomi, A; Brini, AT; Ceserani, V; Coccè, V; Ghezzi, E; Guercio, A; Parati, E; Pascucci, L; Pessina, A; Pettinari, L; Zeira, O | 1 |
| Lu, W; Mao, J; Ran, D; Shen, Q; Wang, S; Xie, C | 1 |
| Wang, L; Wang, Y | 1 |
| Chai, Z; Gao, B; Guan, J; Hu, X; Liu, J; Liu, X; Lu, W; Qian, J; Yang, Y; Zhan, C; Zhang, Z | 1 |
| Hu, Y; Jiang, T; Jiang, X; Jin, K; Luo, Z; Mei, H; Pang, Z; Shi, W; Tuo, Y; Zhang, B | 1 |
| Hou, Y; Li, B; Wang, X; Yang, J; Yi, L; Zhang, Z | 1 |
| Hu, Y; Huang, J; Shu, Y; Wang, L; Wu, D; Yang, Y; Zhang, J; Zheng, J | 1 |
| Cizkova, D; Duhamel, M; Fournier, I; Kobeissy, F; Murgoci, AN; Nataf, S; Pays, L; Régnier-Vigouroux, A; Rodet, F; Rose, M; Salzet, M; Vanden Abeele, F; Wisztorski, M; Zografidou, L | 1 |
| Chai, Z; Chen, X; Lu, W; Ruan, H; Shen, Q; Su, B; Wang, H; Xie, C; Yao, S; Ying, M; Zhan, C; Zhang, M | 1 |
| Jiang, K; Lu, W; Ruan, H; Wang, F; Wang, H; Wang, S; Wang, X; Xie, C; Zhan, C; Zhang, M | 1 |
| Chen, X; Cun, X; He, Q; Li, M; Shi, K; Tang, X; Wei, J; Yu, Q; Zhang, Z | 1 |
| Chen, Y; Guo, L; Peng, Y; Wu, Y; Xiao, W; Yang, J; Yang, Z; Zhang, L; Zhao, Y | 1 |
| Gao, J; Lv, Y; Ouyang, X; Sun, X; Wang, J; Wang, X | 1 |
| Borrós, S; Brugada Vilà, P; Cascante, A; Di Mauro, PP; Gómez-Vallejo, V; Llop, J | 1 |
| Cai, K; Song, T; Xu, M; Yan, L; Zhao, T | 1 |
| Gao, H; Hu, C; Liu, R; Qin, L; Su, D; Wang, G; Yang, C; Yang, X; Yang, Y; Yu, M; Zhou, Y | 1 |
| Chow, PK; Davoodi, P; Lei, C; Wang, CH; Zhan, W | 1 |
| Chen, Y; Fu, Q; Guo, L; Wu, Y; Xiao, W; Yang, Y; Yang, Z; Yue, Q; Zhao, Y | 1 |
| Bashllari, R; Cimino, F; Costa, G; Ferlazzo, G; Fratantonio, D; Molonia, MS; Muscarà, C; Saija, A; Speciale, A | 1 |
| Jiang, K; Lu, W; Wang, H; Wang, R; Wang, S; Wang, X; Xie, C; Zhan, C | 1 |
| Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, M; Jiang, X; Kang, T; Liu, Z; Miao, D; Pang, Z; Song, Q; Tu, Y; Yao, L | 1 |
| Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, X; Kang, T; Liu, Z; Pang, Z; Song, Q; Tu, Y; Yao, L | 1 |
| Chow, PK; Cui, Y; Wang, CH; Wang, D; Xu, Q | 1 |
| Fan, X; Li, X; Ni, S; Qi, H; Wang, J | 1 |
| Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, M; Kang, T; Li, W; Liu, Z; Miao, D; Song, Q; Sun, M; Yao, L | 1 |
| Chen, J; Hu, Y; Jiang, X; Liao, Z; Mei, H; Pang, Z; Shen, S; Shi, W; Wang, H; Wang, Y; Yang, J; Zhang, B | 1 |
| Chen, H; Chen, J; Feng, X; Gao, X; Hu, Q; Huang, M; Jiang, D; Jiang, X; Kang, T; Pang, Z; Song, Q; Yao, L; Zhang, X | 1 |
| Brem, H; Gabikian, P; Li, KW; Tyler, BM; Walter, KA; Zhang, I | 1 |
| Chen, J; Gao, H; He, Q; Kuang, Q; Liu, Y; Mei, L; Ran, R; Tang, J; Zhang, Q; Zhang, Z | 1 |
| Ju, RJ; Li, XT; Li, XY; Lou, JN; Lu, WL; Mu, LM; Shi, JF; Sun, MG; Zeng, F; Zhang, CX; Zhao, WY; Zhao, Y | 1 |
| Chen, H; Chen, J; Feng, X; Gao, X; Gu, G; Hu, Q; Jiang, D; Kang, T; Menglin, J; Song, Q | 1 |
| Hanes, J; Nance, E; Schuster, BS; Shih, TY; Xu, Q; Zhang, C | 1 |
| Chen, J; Hu, Y; Jiang, T; Jiang, X; Liao, Z; Pang, Z; She, X; Shen, S; Tuo, Y; Zhang, B; Zhang, Q; Zhang, Y; Zhao, J | 1 |
| Benoit, JP; Bossiere, M; Groo, AC; Lagarce, F; Legras, P; Trichard, L | 1 |
| Camorani, S; Cerchia, L | 1 |
| Gao, H; He, Q; Liu, Y; Mei, L; Qiu, Y; Shi, K; Xu, C; Yang, Y; Yu, Q; Zhang, Q; Zhang, Z | 1 |
| Chi, Y; Dai, Y; Li, Z; Wang, C; Zhang, L; Zhou, L; Zhu, S | 1 |
| Gao, H; He, Q; Liu, Y; Long, Y; Qiu, Y; Shi, K; Wang, Y; Xu, C; Yu, Q; Zhang, Q; Zhang, Z | 1 |
| Chen, HM; Guan, DG; Liao, SF; Zhao, TZ | 1 |
| Chao, CC; Chien, CL; Kan, D; Lo, TH; Lu, KS | 1 |
| Aiba, N; Itoh, G; Iwabuchi, Y; Kohyama, A; Kuriyama, S; Shibata, H; Tanaka, M; Yashiro, M | 1 |
| Ahmed, W; Elhissi, AM; Kadam, A; Najlah, M; Taylor, KM; Wan, KW | 1 |
| Bandyopadhyay, AK; Banerjee, I; Chattopadhyay, S; De, K; Dey, G; Ganguly, S; Gupta, A; Mandal, M; Misra, M; Mukherjee, D; Mukherjee, M | 1 |
| Chen, Y; Fang, X; Gao, F; Huang, Y; Liu, W | 1 |
| Chunlei, C; Jingjing, W; Tianqin, G | 1 |
| Castro, MG; Doherty, R; Lowenstein, PR; Wilson, TJ; Zamler, DB | 1 |
| Chen, J; Feng, J; Hu, Q; Jiang, T; Jiang, X; Kang, T; Yao, J; Zhu, Q | 1 |
| Du, T; Gou, M; Gou, Z; Hu, Y; Mao, J; Tao, J; Yang, Y; Zhang, J | 1 |
| Gong, M; Li, Y; Zhang, J; Zheng, X | 1 |
| Cui, Y; Huang, Y; Jin, H; Xu, Q; Zeng, F; Zhang, M | 1 |
| Chen, X; Gao, J; Lu, W; Ying, M; Zhan, C; Zhang, M | 1 |
| Do, L; Dou, H; Payne, G; Rodriguez, J; Tao, Y; Thomas, T; Zou, L | 1 |
| Chen, Y; Feng, S; Gao, F; Liu, W; Yin, P; Yuan, Z | 1 |
| Haapa-aho, V; Järvinen, K; Korhonen, H; Pikkarainen, J; Pulkkinen, M; Seppälä, J; Tarvainen, T; Wirth, T | 1 |
| Mirimanoff, RO | 1 |
| Carlotti Júnior, CG; Colli, BO; Montemor, JP; Monti, CR; Peria, FM; Petrilli, LS | 1 |
| Patel, R; Shervington, A | 1 |
| Akiyama, Y; Bögler, O; Fujiwara, K; Kondo, S; Moritake, K; Shingu, T; Shinojima, N; Tamada, Y; Yokoyama, T | 1 |
| Fukunaka, Y; Hirano, G; Izumi, H; Kashiwagi, E; Kidani, A; Kohno, K; Masubuchi, D; Miyamoto, N; Naito, S; Nishizawa, S; Sasaguri, Y; Shiota, M; Takahashi, M; Tanimoto, A; Yasuniwa, Y | 1 |
| Chaudhari, K; Dantuluri, P; Das, S; Murthy, RS; Shah, N | 1 |
| Gupta, S; Li, C; Shao, R; Wei, X; You, J | 1 |
| Chen, XM; Huang, Y; Ke, XY; Wang, Y; Zhang, Q; Zhang, X; Zhao, BJ; Zhao, BX; Zhao, SS; Zhao, X | 1 |
| Diaz, R; Hallahan, DE; Harth, E; Passarella, RJ; Phillips, JG; Sathiyakumar, V; Spratt, DE; van der Ende, AE; Wu, H; Zhou, L | 1 |
| Chu, SH; Feng, DF; Ma, YB; Qiu, JH; Zhang, H; Zhu, ZA | 1 |
| Chang, J; Li, A; Liang, C; Tai, J; Wang, H; Yan, R; Zhang, J; Zhao, M | 1 |
| Chen, XM; Huang, Y; Ke, XY; Lou, JN; Lu, WL; Zhang, Q; Zhang, X; Zhao, BJ; Zhao, BX; Zhao, X | 1 |
| Bui, T; Geldenhuys, W; Harrison, K; Mbimba, T; Sutariya, V | 1 |
| Chang, J; Li, A; Liang, S; Wang, H; Yan, R; Zhang, J; Zhao, M | 1 |
| Chen, H; Chen, J; Gao, X; Gu, G; Guo, J; Jiang, X; Pang, Z; Su, L; Xia, H; Yao, L | 1 |
| Abulrob, A; Béliveau, R; Bertrand, Y; Castaigne, JP; Currie, JC; Demeule, M; Fatehi, D; Poirier, J; Sartelet, H; Stanimirovic, D | 1 |
| Chen, J; Guo, L; Jiang, X; Li, J; Pang, Z; Qian, Y; Qiu, B; Ren, J; Sun, X; Ye, H; Zhang, Q | 1 |
| Hu, X; Jing, X; Wang, Z; Yue, J | 1 |
| Feng, L; Hu, L; Li, Y; Yin, Q; Zhang, P; Zhang, Z | 1 |
| Feng, L; Hu, L; Li, Y; Yin, Q; Zhang, P | 1 |
| Boxerman, J; Jeyapalan, S; Raghavan, D; Rogg, J | 1 |
| Ou, S; Qiu, B; Sun, X; Tao, J; Wang, Y; Zhang, D | 1 |
| Dou, H; Ning, M; Tao, Y | 1 |
| Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, M; Jiang, X; Kang, T; Liu, Z; Miao, D; Pang, Z; Song, Q; Tu, Y; Xia, H; Yao, L | 1 |
| Brem, H; Eberhart, CG; Fowers, KD; Hwang, L; Li, KW; Okonma, S; Recinos, VR; Tyler, BM; Vellimana, AK; Zhang, Y | 1 |
| Du, R; Duan, Y; Hu, X; Huang, D; Ke, XY; Li, D; Li, JS; Li, XH; Ren, W; Song, P; Yang, K; Yu, KF; Zhang, Q; Zhang, X | 1 |
| Brenner, A; Castaigne, JP; Drappatz, J; Eichler, A; Elian, K; Fielding, RM; Groves, MD; Kelsey, S; Lawrence, B; Meyers, CA; Mikkelsen, T; Rosenfeld, S; Sarantopoulos, J; Schiff, D; Shing, M; Wang, X; Wen, PY; Wong, ET | 1 |
| Chen, L; Chen, S; Chen, Y; Fang, X; Gu, J; Jiang, X; Sha, X; Xia, W; Xie, Y; Xin, H; Xu, X | 1 |
| Boxerman, J; Cielo, D; Constantinou, M; Dipetrillo, T; Donahue, J; Elinzano, H; Evans, D; Goldman, M; Isdale, D; Jeyapalan, S; Kinsella, T; Mantripragada, K; Oyelese, A; Puthawala, Y; Rosati, K; Safran, H; Santaniello, A; Stopa, E | 1 |
| Bauer, B; Bernhardt, G; Buschauer, A; Fankhänel, M; Färber, L; Fellner, S; Fricker, G; Graeff, C; Gschaidmeier, H; Miller, DS; Schaffrik, M; Spruss, T | 1 |
| Köhler, A; Könemann, S; Mosler, C; Müller, SB; Rübe, C; Rübe, CE; Schuck, A; Wassmann, H; Wienstroer, M; Willich, N | 1 |
| Baayen, HC; Barkhof, F; Boogerd, W; Castelijns, JA; Elkhuizen, PH; Heimans, JJ; Postma, TJ; Uitdehaag, BM; Vos, MJ | 1 |
| Hara, N; Moritake, K; Osago, H; Shingu, T; Terashima, M; Tsuchiya, M; Uemura, T; Yamada, K; Yamasaki, T | 1 |
| Bilzer, T; Gorol, M; Kondakci, M; Rommel, F; Sabel, M; Willers, R | 1 |
| Brem, H; Dang, W; Li, KW; Tihan, T; Troiano, G; Tyler, BM; Walter, KA | 1 |
| Faibel, M; Hadani, M; Jonas, T; Lidar, Z; Mardor, Y; Nass, D; Pfeffer, R; Ram, Z | 1 |
| Ding, L; Lee, T; Wang, CH | 1 |
| Ayral-Kaloustian, S; Cai, P; Chaudhary, I; Fawzi, M; Frost, P; Gaydos, C; Gibbons, J; Gu, J; Li, F; Lotvin, J; Lucas, J; Mansour, T; Petersen, R; Ruppen, M; Skotnicki, J; Toral-Barza, L; Yu, K; Zask, A; Zhu, T | 1 |
| Bjerkvig, R; Goldbrunner, R; Kerkau, S; Martini, R; Schichor, C; Tonn, JC; Visted, T | 1 |
| Wang, CH; Xie, J | 2 |
| Marijnissen, JC; Wang, CH; Xie, J | 1 |
| Altinoz, MA; Bilir, A; Del Maestro, RF; Gedikoglu, G; Ozcan, E; Tuna, S | 1 |
| Groves, MD; Jeon, JW; Kang, CM; Kim, JH; Kim, JT; Kim, MH; Kim, YJ; Nam, DH; Park, K; Park, SY; Son, MJ; Song, HS | 1 |
| Aubert-Pouessel, A; Benoît, JP; Denizot, B; Garcion, E; Heurtault, B; Lamprecht, A; Menei, P; Paillard, A | 1 |
| Barger, G; Brem, H; Brem, S; Fruehauf, JP; Huang, W; Parker, R; Sloan, A | 1 |
| Hiratsuka, M; Inoue, T; Ito, H; Katoh, M; Kishimoto, I; Nakano, S; Osaki, M; Oshimura, M; Yamada, H; Yamaguchi, S | 1 |
| Kam Yiu Lee, T; Kumar Naraharisetti, P; Sahinidis, NV; Wang, CH; Wei Xie, J; Yung Sheng Ong, B | 1 |
| Fok, PT; Holland, PC; Huang, KC; Nalbantoglu, J | 1 |
| Ashamalla, H; Colella, F; Dosik, D; Guriguis, A; Krishnamurthy, M; Lavaf, A; Lewis, L; Mokhtar, B; Nasr, H; Saad, N; Zaki, B | 1 |
| Dong, Y; Feng, SS | 1 |
| Kiessling, F; Kobayashi, M; Koike, K; Richter, GM; Semmler, W; Stampfl, U; Stiller, W | 1 |
| Bergquist, H; Gee, MS; Josephson, L; Mahmood, U; Upadhyay, R; Weissleder, R | 1 |
| Tan, JC; Wang, CH; Xie, J | 1 |
| Goldbrunner, R; Holtmannspötter, M; Tanner, PG; Tonn, JC | 1 |
| Lea, R; Patel, R; Shervington, A; Shervington, L | 1 |
| Allegrini, PR; Brueggen, J; Floersheimer, A; Maira, M; McSheehy, PM; O'Reilly, T; Wartmann, M | 1 |
| Ranganath, SH; Wang, CH | 1 |
| Beaman-Hall, CM; Vallano, ML | 1 |
| Calabresi, P; Choy, H; Egorin, MJ; Glantz, MJ; Kearns, CM; Mills, PC; Wahlberg, LU; Zuhowski, EG | 1 |
| Beijnen, JH; Eeltink, CM; Heimans, JJ; Meijer, OW; Taphoorn, MJ; Vermorken, JB; Wolbers, JG | 1 |
| Chuang, DM; Fukamauchi, F; Hough, C | 1 |
| Brem, H; Cahan, MA; Colvin, OM; Walter, KA | 1 |
| Brem, H; Burger, PC; Cahan, MA; Colvin, OM; Domb, A; Gur, A; Hilton, J; Tyler, B; Walter, KA | 1 |
| Gabel, M; Khil, MS; Kim, JH; Kim, SH; Lee, YJ; Ryu, S | 1 |
| Berger, MS; Chang, SM; Fulton, D; Gilbert, MR; Kuhn, J; Lamborn, K; McAllister, LD; Mehta, MP; Prados, MD; Rector, DJ; Schold, SC; Spence, AM | 1 |
| Inaguma, Y; Ito, H; Kato, K; Okamoto, K; Saga, S | 1 |
| Cairncross, G; Eisenhauer, E; Forsyth, P; Goodyear, M; Stewart, D; Wainman, N | 1 |
| Deen, DF; Gupta, N; Hu, LJ | 1 |
| Barbarese, E; D'Arrigo, JS; Ho, SY; Simon, RH; Smith-Slatas, C | 1 |
| Arnold, H; Bjerkvig, R; Dahl, O; Gundersen, G; Heese, O; Terzis, AJ; Thorsen, F; Visted, T | 1 |
| Fueyo, J; Gomez-Manzano, C; Kyritsis, AP; Levin, VA; Martin-Duque, P; Perez-Soler, R; Puduvalli, VK; Yung, WK | 1 |
| Dichgans, J; Grimmel, C; Roth, W; Wagenknecht, B; Weller, M | 1 |
| Berger, MS; Bozik, ME; Chang, SM; Fulton, D; Gilbert, M; Kuhn, JG; Malec, M; Mehta, MP; Pollack, I; Prados, MD; Rankin, C; Rizzo, J; Robins, HI; Schold, SC; Spence, AM | 1 |
| Gao, Y; Kunapuli, SP; Ravindra, R; Singh, LD; Singh, SP | 1 |
| Bradac, GB; Rudà, R; Schiffer, D; Soffietti, R | 1 |
| Borbé, R; Rieger, J; Weller, M | 1 |
| Bartussek, C; Naumann, U; Weller, M | 1 |
| Agostino, M; Bartus, RT; Emerich, DF; Marsh, J; Perkins, A; Snodgrass, P | 1 |
| Berger, MS; Chang, SM; Kuhn, JG; Mehta, M; Pollack, IF; Prados, MD; Rankin, C; Robins, HI; Schold, SC; Spence, AM | 1 |
| Chen, Y; Dan, Q; Delgado, C; Jadus, MR; Jeffes, EW; Sanchez, R; Sippel, B; Tran, TV; Trinh, H; Wepsic, HT; Williams, CC | 1 |
| Broët, P; Delattre, JY; Hoang-Xuan, K; Keime-Guibert, F; Napolitano, M; Sanson, M; Yaya, R | 1 |
| Cohen, JS; Faibel, M; Hadani, M; Jonas, T; Lidar, Z; Maier, SE; Mardor, Y; Nass, D; Orenstein, A; Pfeffer, R; Ram, Z; Roth, Y | 1 |
| Frankel, LS; Liu, L; Munoz, LK; Rosenthal, DI; Strauss, LC; Vapiwala, N; Weitman, S; Winick, NJ | 1 |
| Bombardelli, E; D'Incalci, M; Laccabue, D; Perego, P; Pratesi, G; Scanziani, E; Tortoreto, M; Veneroni, S; Zaffaroni, M; Zucchetti, M; Zunino, F | 1 |
| Berman, E; Gallo, JM; Ma, J; Murphy, M; O'Dwyer, PJ; Reed, K | 1 |
| Koszka, C; Leichtfried, FE; Wiche, G | 1 |
1 review(s) available for paclitaxel and Glial Cell Tumors
15 trial(s) available for paclitaxel and Glial Cell Tumors
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Concurrent chemoradiotherapy with weekly paclitaxel in malignant cerebral glioma treatment.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Survival Analysis; Survival Rate; Treatment Outcome | 2008 |
Phase I study of GRN1005 in recurrent malignant glioma.
Topics: Adult; Aged; Antineoplastic Agents; Blood-Brain Barrier; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Glioma; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Peptides | 2013 |
Paclitaxel poliglumex, temozolomide, and radiation for newly diagnosed high-grade glioma: a Brown University Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Brain Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Paclitaxel; Polyglutamic Acid; Survival Analysis; Temozolomide | 2014 |
Combined radiochemotherapy with paclitaxel in the treatment of malignant glioma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiation Dosage; Radiation-Sensitizing Agents; Survival Analysis; Time Factors | 2002 |
Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Convection; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Female; Frontal Lobe; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Parietal Lobe; Prospective Studies; Temporal Lobe | 2004 |
Fractionated stereotactic radiotherapy boost and weekly paclitaxel in malignant gliomas clinical and pharmacokinetics results.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Glioma; Humans; Male; Middle Aged; Paclitaxel; Phenytoin; Radiosurgery; Survival Analysis; Treatment Outcome | 2007 |
Effects of drug efflux on convection-enhanced paclitaxel delivery to malignant gliomas: technical note.
Topics: Adult; Aged; Brain Neoplasms; Convection; Drug Delivery Systems; Female; Glioma; Humans; Infusions, Intralesional; Male; Middle Aged; Paclitaxel | 2007 |
Phase II study of paclitaxel in patients with recurrent malignant glioma.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Canada; Drug Administration Schedule; Female; Glioma; Humans; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Paclitaxel; Remission Induction; Survival Rate; United States | 1996 |
Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Docetaxel; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Taxoids | 1996 |
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.
Topics: Adult; Aged; Anticonvulsants; Brain Neoplasms; Female; Glioma; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Survival Rate; Treatment Outcome | 1998 |
PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Disease Progression; Female; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Paclitaxel; Radiotherapy, Adjuvant; Taxoids; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 1998 |
A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: a North American Brain Tumor Consortium report.
Topics: Adolescent; Adult; Anticonvulsants; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Confidence Intervals; Female; Glioma; Humans; Injections, Intravenous; Male; Middle Aged; Paclitaxel; Treatment Failure | 2001 |
Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: a phase II study.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Docetaxel; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Survival Rate; Taxoids; Time Factors; Treatment Outcome | 2000 |
A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors.
Topics: Adolescent; Brain; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Paclitaxel; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Survival Analysis; Treatment Outcome | 2001 |
161 other study(ies) available for paclitaxel and Glial Cell Tumors
| Article | Year |
|---|---|
Cell-based screen for identification of inhibitors of tubulin polymerization.
Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured | 1996 |
Antiglioma action of xanthones from Gentiana kochiana: Mechanistic and structure-activity requirements.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Death; Cell Division; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; G1 Phase; G2 Phase; Gentiana; Glioma; Humans; Mitochondrial Membranes; Plant Extracts; Rats; Reactive Oxygen Species; Resting Phase, Cell Cycle; Structure-Activity Relationship; Xanthones | 2008 |
Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.
Topics: alpha Karyopherins; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Glioma; Glucosephosphate Dehydrogenase; HSP110 Heat-Shock Proteins; Humans; Magnetic Resonance Spectroscopy; Mice, Nude; Microtubule-Associated Proteins; Molecular Docking Simulation; Molecular Structure; STAT3 Transcription Factor; Structure-Activity Relationship; Thioredoxin Reductase 1; Trans-Activators; Vimentin; Xenograft Model Antitumor Assays | 2015 |
Unprecedented sugar bridged bisindoles selective inhibiting glioma stem cells.
Topics: Alstonia; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioma; Humans; Indoles; Molecular Structure; Neoplastic Stem Cells; Plant Leaves; Structure-Activity Relationship; Sugars; Tumor Cells, Cultured | 2018 |
The 3-D conformational shape of N-naphthyl-cyclopenta[d]pyrimidines affects their potency as microtubule targeting agents and their antitumor activity.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Proliferation; Cyclopentanes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Glioma; Humans; Male; Mice; Mice, Nude; Microtubules; Models, Molecular; Molecular Conformation; Neoplasms, Experimental; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Cholesterol; Drug Delivery Systems; Glioma; Liposomes; Mice; Paclitaxel | 2021 |
Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo.
Topics: Amyloid beta-Peptides; Animals; Antineoplastic Agents; Apolipoproteins E; Blood-Brain Barrier; Brain; Cell Line; Cell Survival; Drug Delivery Systems; Glioma; Humans; Mice; Micelles; Nanoparticles; Paclitaxel; Peptide Fragments; Polyesters; Polyethylene Glycols; Protein Corona | 2021 |
TfR-T12 short peptide and pH sensitive cell transmembrane peptide modified nano-composite micelles for glioma treatment via remodeling tumor microenvironment.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Glioma; Hydrogen-Ion Concentration; Mice; Micelles; Paclitaxel; Peptides; Polyethylene Glycols; Tumor Microenvironment | 2022 |
Tumor Tropic Delivery of Hyaluronic Acid-Poly (D,L-lactide-co-glycolide) Polymeric Micelles Using Mesenchymal Stem Cells for Glioma Therapy.
Topics: Animals; Cell Line, Tumor; Dioxanes; Drug Carriers; Drug Delivery Systems; Glioma; Hyaluronic Acid; Mesenchymal Stem Cells; Micelles; Paclitaxel; Polymers; Rats | 2022 |
Manganese Dioxide-Based Nanocarrier Delivers Paclitaxel to Enhance Chemotherapy against Orthotopic Glioma through Hypoxia Relief.
Topics: Animals; Dihydroxyphenylalanine; Glioma; Hypoxia; Manganese Compounds; Oxides; Paclitaxel; Rats; Tumor Microenvironment | 2022 |
Multifunctional Hybrid Hydrogel System Enhanced the Therapeutic Efficacy of Treatments for Postoperative Glioma.
Topics: Cell Line, Tumor; Copper; Glioma; Humans; Hydrogels; Hydrogen Peroxide; Nanoparticles; Paclitaxel; Photochemotherapy; Prodrugs; Tumor Microenvironment | 2022 |
Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma.
Topics: Berberine; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Folic Acid; Glioma; Humans; Hydrogen-Ion Concentration; Liposomes; Paclitaxel; Polysorbates; Tumor Microenvironment | 2022 |
Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Glioma; Mice; Mice, Inbred NOD; Mice, SCID; Nanoparticles; Paclitaxel; Transferrin | 2023 |
Polysorbate 80-coated albumin nanoparticles to deliver paclitaxel into the brain to treat glioma.
Topics: Brain; Cell Line, Tumor; Drug Carriers; Glioma; Humans; Nanoparticles; Paclitaxel; Polysorbates; Serum Albumin, Bovine; Tissue Distribution | 2023 |
Exploring the Potential of Lapatinib, Fulvestrant, and Paclitaxel Conjugated with Glycidylated PAMAM G4 Dendrimers for Cancer and Parasite Treatment.
Topics: Animals; Caenorhabditis elegans; Carcinoma, Non-Small-Cell Lung; Dendrimers; Fulvestrant; Glioma; Humans; Lapatinib; Lung Neoplasms; Paclitaxel; Parasites | 2023 |
Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations.
Topics: Albumins; Animals; Blood-Brain Barrier; Drug Compounding; Drug Delivery Systems; Female; Glioma; Male; Mice; Mice, Nude; Microbubbles; Nanoparticles; Paclitaxel; Polyethylene Glycols; Survival Rate; Tissue Distribution; Ultrasonography; Xenograft Model Antitumor Assays | 2020 |
Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment.
Topics: Animals; Apoferritins; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioma; Humans; Mice; Mice, Inbred BALB C; Paclitaxel; Tissue Distribution | 2020 |
All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Endoplasmic Reticulum Chaperone BiP; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Micelles; Paclitaxel; Peptides; Polyethylene Glycols; Rats, Sprague-Dawley; Sesquiterpenes; Temozolomide | 2020 |
siRNA and chemotherapeutic molecules entrapped into a redox-responsive platform for targeted synergistic combination therapy of glioma.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Glioma; Humans; Microscopy, Electron, Transmission; Oxidation-Reduction; Paclitaxel; RNA Interference; RNA, Small Interfering; Vascular Endothelial Growth Factor A | 2020 |
The enhanced treatment efficacy of invasive brain glioma by dual-targeted artemether plus paclitaxel micelles.
Topics: Animals; Artemether; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Interactions; Glioma; Mice; Mice, Inbred ICR; Micelles; Molecular Targeted Therapy; Neoplasm Invasiveness; Paclitaxel | 2020 |
Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics.
Topics: Animals; Antibiotics, Antineoplastic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Delivery Systems; Drug Liberation; Exosomes; Glioma; Humans; Lab-On-A-Chip Devices; Microfluidics; Microscopy, Electron, Transmission; Paclitaxel | 2020 |
Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Glioma; Humans; Mice; Nanoparticles; Paclitaxel; Peptides; Porosity; Silicon Dioxide | 2021 |
Biotin and glucose co-modified multi-targeting liposomes for efficient delivery of chemotherapeutics for the treatment of glioma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biotin; Blood-Brain Barrier; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Glioma; Glucose; Ligands; Liposomes; Male; Mice; Mice, Inbred Strains; Molecular Structure; Paclitaxel; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Ginsenosides; Glioma; Liposomes; Mice; Mice, Inbred BALB C; Paclitaxel; Rats; Tumor Microenvironment | 2021 |
Tenascin C Promotes Glioma Cell Malignant Behavior and Inhibits Chemosensitivity to Paclitaxel via Activation of the PI3K/AKT Signaling Pathway.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Glioma; Humans; Paclitaxel; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Tenascin | 2021 |
Self-Assembly Iron Oxide Nanoclusters for Photothermal-Mediated Synergistic Chemo/Chemodynamic Therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Growth Processes; Cell Line, Tumor; Chemoradiotherapy; Drug Synergism; Glioma; Humans; Infrared Rays; Integrin alphaVbeta3; Magnetic Iron Oxide Nanoparticles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Paclitaxel; Rats; Reactive Oxygen Species; Serum Albumin, Human; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2021 |
Near infrared light fluorescence imaging-guided biomimetic nanoparticles of extracellular vesicles deliver indocyanine green and paclitaxel for hyperthermia combined with chemotherapy against glioma.
Topics: Animals; Biomimetics; Caspase 3; Cell Line, Tumor; Drug Therapy; Extracellular Vesicles; Fluorescence; Glioma; Humans; Hyperthermia; Indocyanine Green; Infrared Rays; Mice; Mice, Nude; Nanoparticles; Neuropilin-1; Optical Imaging; Paclitaxel; RAW 264.7 Cells | 2021 |
GRP78 enabled micelle-based glioma targeted drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Endoplasmic Reticulum Chaperone BiP; Glioma; Heat-Shock Proteins; Humans; Insect Hormones; Male; Mice, Inbred BALB C; Mice, Nude; Micelles; Paclitaxel; Rats, Sprague-Dawley; Tumor Burden | 2017 |
Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta Catenin; Brain Neoplasms; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Chromatin Immunoprecipitation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioma; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Paclitaxel; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction | 2017 |
INHIBITION OF PACLITAXEL AGAINST NEUROGLIOMA CELLS U251 GROWTH AND ITS MECHANISM.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Brain Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Glioma; Humans; Paclitaxel | 2017 |
d-Retroenantiomer of Quorum-Sensing Peptide-Modified Polymeric Micelles for Brain Tumor-Targeted Drug Delivery.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioma; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Paclitaxel; Peptides | 2017 |
Thermoresponsive nanocomposite gel for local drug delivery to suppress the growth of glioma by inducing autophagy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Synergism; Glioma; Hydrogels; Male; Nanocomposites; Nanoparticles; Paclitaxel; Rats; Rats, Wistar; Temozolomide; Temperature | 2017 |
Paclitaxel loaded phospholipid-based gel as a drug delivery system for local treatment of glioma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Gels; Glioma; Male; Mice; Mice, Inbred BALB C; Paclitaxel; Phospholipids | 2017 |
Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioma; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; Neutrophils; Paclitaxel; Xenograft Model Antitumor Assays | 2017 |
Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines.
Topics: Adipose Tissue; Animals; Antineoplastic Agents, Phytogenic; Bone Marrow Cells; Cell Line, Tumor; Dogs; Drug Delivery Systems; Glioblastoma; Glioma; Humans; Mesenchymal Stem Cells; Paclitaxel | 2017 |
EGFR/EGFRvIII Dual-Targeting Peptide-Mediated Drug Delivery for Enhanced Glioma Therapy.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; ErbB Receptors; Glioma; Humans; Mice, Inbred BALB C; Paclitaxel; Peptides; Tissue Distribution | 2017 |
miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1.
Topics: 3' Untranslated Regions; Apoptosis; B7-H1 Antigen; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Progression; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioma; Humans; MicroRNAs; Paclitaxel | 2017 |
Cholera Toxin Subunit B Enabled Multifunctional Glioma-Targeted Drug Delivery.
Topics: Animals; Blood-Brain Barrier; Cell Line, Tumor; Cholera Toxin; Drug Delivery Systems; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; RAW 264.7 Cells; Xenograft Model Antitumor Assays | 2017 |
Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels.
Topics: Animals; Antineoplastic Agents; Bradykinin; Brain Neoplasms; Capillary Permeability; Captopril; Cell Line, Tumor; Drug Delivery Systems; Endothelium, Vascular; Glioma; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Nanoparticles; Paclitaxel; Regional Blood Flow; Time Factors; Tumor Burden; Vasodilator Agents; Xenograft Model Antitumor Assays | 2017 |
Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Emulsions; Female; Glioma; Hep G2 Cells; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Microspheres; Nanoparticles; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2018 |
MAD2-p31
Topics: Adaptor Proteins, Signal Transducing; Brain Neoplasms; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cellular Senescence; Clone Cells; Glioma; Humans; Mad2 Proteins; Microtubules; Nuclear Proteins; Paclitaxel; Vinblastine | 2018 |
Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line; Cell Survival; Coculture Techniques; Cytokines; Glioma; Macrophages; Paclitaxel; Proprotein Convertase 1; Proteomics; Rats | 2018 |
A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Computer-Aided Design; Drug Carriers; Drug Delivery Systems; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Ligands; Low Density Lipoprotein Receptor-Related Protein-1; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Oligonucleotides; Paclitaxel; Polyethylene Glycols; Tissue Distribution | 2018 |
Nanodisk-based glioma-targeted drug delivery enabled by a stable glycopeptide.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Glioma; Glycopeptides; Humans; Male; Mice, Inbred ICR; Nanostructures; Oligopeptides; Paclitaxel | 2018 |
pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell-Penetrating Peptides; Female; Folate Receptors, GPI-Anchored; Folic Acid; Glioma; Hydrogen-Ion Concentration; Liposomes; Mice, Inbred BALB C; Molecular Targeted Therapy; Paclitaxel; Phosphatidylethanolamines; Polyethylene Glycols | 2018 |
Dual-targeting for brain-specific liposomes drug delivery system: Synthesis and preliminary evaluation.
Topics: Animals; Ascorbic Acid; Brain; Cell Line, Tumor; Drug Liberation; Drug Stability; Fluorescent Dyes; Glioma; Glucose; Half-Life; Liposomes; Mice; Microscopy, Confocal; Optical Imaging; Paclitaxel; Rats; Tissue Distribution; Transplantation, Heterologous | 2018 |
Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
Topics: Adipogenesis; Animals; Antineoplastic Agents; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Movement; Drug Carriers; Drug Delivery Systems; Endocytosis; Glioma; Humans; Kinetics; Lactic Acid; Male; Mesenchymal Stem Cells; Nanoparticles; Osteogenesis; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Tissue Distribution | 2018 |
Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cattle; Cell Line, Tumor; Cells, Cultured; Delayed-Action Preparations; Drug Delivery Systems; Endothelial Cells; Glioblastoma; Glioma; Humans; Nanoparticles; Paclitaxel; Peptides; Polymers; Rats; Rats, Sprague-Dawley; Receptors, LDL; Tissue Distribution | 2018 |
Downregulation of long noncoding RNA PVT1 attenuates paclitaxel resistance in glioma cells.
Topics: Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioma; Humans; Paclitaxel; RNA, Long Noncoding | 2018 |
D-T7 Peptide-Modified PEGylated Bilirubin Nanoparticles Loaded with Cediranib and Paclitaxel for Antiangiogenesis and Chemotherapy of Glioma.
Topics: Animals; Bilirubin; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Collagen Type IV; Drug Carriers; Glioma; Humans; Male; Mice; Nanoparticles; Paclitaxel; Peptide Fragments; Quinazolines | 2019 |
Development of Nanoparticles for Drug Delivery to Brain Tumor: The Effect of Surface Materials on Penetration Into Brain Tissue.
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Glioma; Lactic Acid; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Polyethylene Glycols; Polyglycolic Acid; Rats; Tissue Distribution; Vitamin E | 2019 |
Liposomes actively recognizing the glucose transporter GLUT
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cell Line; Cell Line, Tumor; Drug Delivery Systems; Glioma; Glucose; Glucose Transporter Type 1; Integrin alphaVbeta3; Liposomes; Mice; Oligopeptides; Paclitaxel | 2019 |
Curcumin potentiates the antitumor activity of Paclitaxel in rat glioma C6 cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Curcumin; Glioma; Humans; NF-kappa B; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Rats; Signal Transduction | 2019 |
Co-delivery of paclitaxel and melittin by glycopeptide-modified lipodisks for synergistic anti-glioma therapy.
Topics: Animals; Brain Neoplasms; Drug Delivery Systems; Female; Glioma; Glycopeptides; Humans; Melitten; Mice; Mice, Nude; Nanoparticles; Paclitaxel; Xenograft Model Antitumor Assays | 2019 |
The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
Topics: Animals; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell-Penetrating Peptides; Coumarins; Diagnostic Imaging; Endocytosis; Glioma; Male; Matrix Metalloproteinase 14; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Oligopeptides; Paclitaxel; Rats; Spheroids, Cellular; Survival Analysis; Tissue Distribution | 2013 |
Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cell-Penetrating Peptides; Coumarins; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Kaplan-Meier Estimate; Male; Mice; Mice, Nude; Nanoparticles; Paclitaxel; Polyethylene Glycols; Rats; Spectroscopy, Near-Infrared; Spheroids, Cellular; Tissue Distribution | 2013 |
Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
Topics: Animals; Cell Line, Tumor; Doxorubicin; Glioma; Humans; Mice; Mice, Nude; Nanoparticles; Paclitaxel | 2013 |
Biodegradable implants efficiently deliver combination of paclitaxel and temozolomide to glioma C6 cancer cells in vitro.
Topics: Absorbable Implants; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dacarbazine; Drug Delivery Systems; Glioma; Humans; Paclitaxel; Temozolomide | 2014 |
Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain; Cells, Cultured; Drug Delivery Systems; Endothelium, Vascular; Glioma; Lactates; Lactoferrin; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Peptides, Cyclic; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Spheroids, Cellular; Tissue Distribution | 2014 |
EGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma.
Topics: Animals; Cell Line; Drug Delivery Systems; Glioma; Green Fluorescent Proteins; Human Umbilical Vein Endothelial Cells; Humans; In Situ Nick-End Labeling; Mice; Nanoparticles; Neovascularization, Pathologic; Paclitaxel; Recombinant Fusion Proteins | 2014 |
iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.
Topics: Administration, Intravenous; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Collagen; Coumarins; Drug Combinations; Endocytosis; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Kaplan-Meier Estimate; Lactic Acid; Laminin; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Neovascularization, Pathologic; Oligopeptides; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proteoglycans; Rats; Rats, Sprague-Dawley; Spectroscopy, Near-Infrared; Thiazoles; Tissue Distribution; Treatment Outcome | 2014 |
Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Drug Delivery Systems; Glioma; Humans; Microspheres; Neoplasm Transplantation; Paclitaxel; Radiation-Sensitizing Agents; Rats; Rats, Inbred F344 | 2014 |
Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioma; Humans; Liposomes; Mice; Mice, Inbred BALB C; Oligopeptides; Paclitaxel | 2014 |
Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemether; Artemisinins; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Dequalinium; Drug Delivery Systems; Glioma; Liposomes; Male; Mannose; Mice; Mice, Inbred ICR; Paclitaxel; Phosphatidylethanolamines; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Vitamin E | 2014 |
PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
Topics: Administration, Intravenous; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Caveolae; Cell Line, Tumor; Cell Proliferation; Collagen; Drug Combinations; Endocytosis; Female; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Laminin; Membrane Microdomains; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasm Transplantation; Paclitaxel; Particle Size; Peptides; Polyethylene Glycols; Protein Structure, Tertiary; Proteoglycans; Temperature | 2014 |
Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration.
Topics: Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Glioma; Humans; Nanoparticles; Paclitaxel | 2014 |
UPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain glioma.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Cell Line, Tumor; Cell-Penetrating Peptides; Drug Delivery Systems; Glioma; Humans; Mice; Mice, Nude; Molecular Sequence Data; Nanoparticles; Paclitaxel; Urokinase-Type Plasminogen Activator | 2015 |
In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor.
Topics: Administration, Oral; Amination; Animals; Antineoplastic Agents, Phytogenic; Cell Line; Female; Glioma; Humans; Injections, Intravenous; Nanocapsules; Paclitaxel; Phosphatidylethanolamines; Polyethylene Glycols; Rats; Rats, Inbred F344 | 2015 |
Oligonucleotide aptamers for glioma targeting: an update.
Topics: Animals; Antineoplastic Agents; Aptamers, Nucleotide; Blood-Brain Barrier; Brain Neoplasms; Clinical Trials as Topic; Drug Carriers; Glioma; Humans; Mice; Molecular Targeted Therapy; Neoplasm Proteins; Paclitaxel; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; SELEX Aptamer Technique; Tenascin; Xenograft Model Antitumor Assays | 2015 |
Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Glioma; Liposomes; Mice, Inbred BALB C; Neoplastic Stem Cells; Neovascularization, Pathologic; Oligopeptides; Paclitaxel; Treatment Outcome | 2015 |
Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.
Topics: Animals; Apoptosis; Cell Line, Tumor; Drug Delivery Systems; Ethylene Glycols; Glioma; Male; Mice; Mice, Nude; Nanoparticles; Paclitaxel; Particle Size; Peptides; Polyesters; Tissue Distribution | 2016 |
Liposomes Combined an Integrin αvβ3-Specific Vector with pH-Responsible Cell-Penetrating Property for Highly Effective Antiglioma Therapy through the Blood-Brain Barrier.
Topics: Animals; Antineoplastic Agents; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Cell Death; Cell Line; Cell Survival; Diagnostic Imaging; Electric Impedance; Endocytosis; Epithelium; Female; Glioma; Hydrogen-Ion Concentration; Integrin alphaVbeta3; Liposomes; Mice, Inbred BALB C; Neoplastic Stem Cells; Paclitaxel; Particle Size; Peptides; Proton Magnetic Resonance Spectroscopy; Spheroids, Cellular; Static Electricity; Surface Plasmon Resonance | 2015 |
Combination of temozolomide and Taxol exerts a synergistic inhibitory effect on Taxol‑resistant glioma cells via inhibition of glucose metabolism.
Topics: Antineoplastic Agents; Brain; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Glioma; Glucose; Humans; Paclitaxel; Temozolomide | 2015 |
Induction of neural differentiation in rat C6 glioma cells with taxol.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Glioma; Nestin; Neurogenesis; Neurons; Paclitaxel; Rats; Real-Time Polymerase Chain Reaction; RNA, Messenger; Tubulin | 2015 |
Identification of anti-cancer chemical compounds using Xenopus embryos.
Topics: Animals; Antineoplastic Agents; Benzodioxoles; Benzofurans; Carbolines; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Evaluation, Preclinical; Embryo Loss; Embryo, Nonmammalian; Female; Gastrulation; Glioma; Indole Alkaloids; Melanoma, Experimental; Mice; Microtubules; Neoplasm Invasiveness; Paclitaxel; Podophyllotoxin; Rats; Receptors, CXCR4; Xenograft Model Antitumor Assays; Xenopus | 2016 |
Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Emulsions; Excipients; Glioma; Humans; Nanoparticles; Paclitaxel; Parenteral Nutrition; Particle Size; Phospholipids; Plant Oils; Solubility; Soybean Oil | 2016 |
Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy.
Topics: Animals; Cell Line, Tumor; Drug Carriers; Glioma; Lipids; Mice; Nanoparticles; Neovascularization, Pathologic; NIH 3T3 Cells; Octreotide; Paclitaxel; Rats | 2016 |
c(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma.
Topics: Animals; Apoptosis; Biological Transport; Blood-Brain Barrier; Body Weight; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Delivery Systems; Endocytosis; Glioma; Humans; Kaplan-Meier Estimate; Male; Mice; Mice, Nude; Micelles; Paclitaxel; Peptides, Cyclic; Poloxamer | 2016 |
Synergistic Anti-glioma Effects in Vitro and in Vivo of Enediyne Antibiotic Neocarzinostatin and Paclitaxel via Enhanced Growth Delay and Apoptosis-Induction.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Glioma; Humans; Male; Mice, Nude; Paclitaxel; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Tumor Burden; Tumor Suppressor Protein p53; Zinostatin | 2016 |
Reversibility of glioma stem cells' phenotypes explains their complex in vitro and in vivo behavior: Discovery of a novel neurosphere-specific enzyme, cGMP-dependent protein kinase 1, using the genomic landscape of human glioma stem cells as a discovery t
Topics: Animals; Apoptosis; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemotaxis; Cyclic GMP-Dependent Protein Kinase Type I; Dacarbazine; Doxorubicin; Female; Glioblastoma; Glioma; Humans; Male; Mice; Mice, Transgenic; Neoplasm Invasiveness; Neoplastic Stem Cells; Neurons; Oligonucleotide Array Sequence Analysis; Paclitaxel; Phenotype; Stem Cells; Temozolomide | 2016 |
Tumor Microenvironment and Angiogenic Blood Vessels Dual-Targeting for Enhanced Anti-Glioma Therapy.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Tumor Microenvironment | 2016 |
A conformal hydrogel nanocomposite for local delivery of paclitaxel.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Liberation; Glioma; Hydrogels; Nanocomposites; Paclitaxel; Rats | 2017 |
Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell-Penetrating Peptides; Drug Delivery Systems; Glioma; Humans; Low Density Lipoprotein Receptor-Related Protein-1; Mice; Nanoparticles; Paclitaxel; Peptides; Xenograft Model Antitumor Assays | 2016 |
Dual-Targeting Magnetic PLGA Nanoparticles for Codelivery of Paclitaxel and Curcumin for Brain Tumor Therapy.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Curcumin; Drug Delivery Systems; Glioma; Lactic Acid; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2016 |
Glioma-Targeted Drug Delivery Enabled by a Multifunctional Peptide.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Micelles; Paclitaxel; Peptides; Polyethylene Glycols | 2017 |
Targeted delivery of nano-PTX to the brain tumor-associated macrophages.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Cell Line, Tumor; Coculture Techniques; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Design; Glioma; Glycoproteins; Humans; Lactic Acid; Ligands; Lipids; Macrophages; Male; Mice, Inbred BALB C; Mice, SCID; Nanoparticles; Neurons; Paclitaxel; Peptide Fragments; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Time Factors; Tissue Distribution; Viral Proteins; Xenograft Model Antitumor Assays | 2017 |
Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Carriers; Glioma; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Nanoparticles; Oligopeptides; Oligosaccharides; Paclitaxel; Particle Size; Succinates; Vitamin E | 2017 |
Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity.
Topics: Animals; Antineoplastic Agents; Avidin; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Glioma; Humans; Nanoparticles; Neoplasms; Paclitaxel; Particle Size; Polyesters; Polyethylene Glycols; Rats; Solubility; Technology, Pharmaceutical; Time Factors; Transferrin | 2008 |
Concurrent chemoradiotherapy for malignant glioma: dead end or highway?
Topics: Antineoplastic Agents; Brain Neoplasms; Glioma; Humans; Neoadjuvant Therapy; Paclitaxel; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
Silencing DNA methyltransferase (DNMT) enhances glioma chemosensitivity.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Dacarbazine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Silencing; Glioma; Humans; Paclitaxel; RNA, Small Interfering; Telomerase; Temozolomide | 2008 |
Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells.
Topics: Adenine; Antineoplastic Agents; Autophagy; Autophagy-Related Protein 5; Benzamides; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cisplatin; Extracellular Signal-Regulated MAP Kinases; Glioma; Humans; Imatinib Mesylate; Macrolides; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Microtubule-Associated Proteins; Paclitaxel; Piperazines; Pyrimidines | 2009 |
Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth.
Topics: Apoptosis Regulatory Proteins; Cell Growth Processes; Cell Line, Tumor; Cisplatin; Down-Regulation; Glioma; Humans; Male; Nuclear Proteins; Paclitaxel; Prostatic Neoplasms; RNA-Binding Proteins; Transcription, Genetic; Transfection; Twist-Related Protein 1; Y-Box-Binding Protein 1 | 2009 |
Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glioma; Lactic Acid; Male; Nanoparticles; Paclitaxel; Poloxalene; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Tissue Distribution; Transferrin | 2009 |
Near-infrared light triggers release of Paclitaxel from biodegradable microspheres: photothermal effect and enhanced antitumor activity.
Topics: Absorbable Implants; Antineoplastic Agents; Cell Line, Tumor; Delayed-Action Preparations; Diffusion; Glioma; Gold; Hot Temperature; Humans; Infrared Rays; Macromolecular Substances; Materials Testing; Microspheres; Molecular Conformation; Nanostructures; Paclitaxel; Surface Properties | 2010 |
The therapeutic efficacy of conjugated linoleic acid - paclitaxel on glioma in the rat.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Glioma; Linoleic Acids, Conjugated; Male; Paclitaxel; Rats; Rats, Sprague-Dawley; Tubulin | 2010 |
Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bacteriophages; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Coculture Techniques; Delayed-Action Preparations; Drug Delivery Systems; Endoplasmic Reticulum Chaperone BiP; Endothelial Cells; Glioma; Heat-Shock Proteins; Humans; Mice; Mice, Inbred C57BL; Mice, Nude; Nanoparticles; Oligopeptides; Paclitaxel; Recombinant Proteins; Xenograft Model Antitumor Assays | 2010 |
c-Met antisense oligodeoxynucleotides increase sensitivity of human glioma cells to paclitaxel.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Caspase 3; Cell Proliferation; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Glioma; Humans; Oligodeoxyribonucleotides, Antisense; Paclitaxel; Proto-Oncogene Proteins c-met; Tumor Cells, Cultured | 2010 |
Magnetic paclitaxel nanoparticles inhibit glioma growth and improve the survival of rats bearing glioma xenografts.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Cerebral Cortex; Glioma; Humans; Magnetics; Nanoparticles; Paclitaxel; Rats; Rats, Sprague-Dawley; Solubility; Xenograft Model Antitumor Assays | 2010 |
The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.
Topics: Angiogenesis Inhibitors; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Drug Carriers; Endothelial Cells; Flow Cytometry; Glioma; Glutamyl Aminopeptidase; Male; Mice; Micelles; Microscopy, Fluorescence; Neoplasm Transplantation; Oligopeptides; Paclitaxel; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Rats; Rats, Sprague-Dawley | 2011 |
Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Neoplasms; Cell Death; Cell Line, Tumor; Coumarins; Delayed-Action Preparations; Drug Delivery Systems; Glioma; Glutathione; Humans; Male; Mice; Mice, Inbred C57BL; Microtubules; Nanoparticles; Paclitaxel; Particle Size; Permeability; Rats; Thiazoles; Tubulin | 2011 |
[Preparation of superparamagnetic paclitaxel nanoparticles from modified chitosan and their cytotoxicity against malignant brain glioma].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Compounding; Ferric Compounds; Glioma; Humans; Magnetics; Metal Nanoparticles; Nanoparticles; Paclitaxel | 2011 |
Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
Topics: Animals; Aptamers, Nucleotide; Cell Proliferation; Drug Delivery Systems; Electrophoresis, Polyacrylamide Gel; Glioma; Humans; Inhibitory Concentration 50; Injections, Intravenous; Kaplan-Meier Estimate; Lactic Acid; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Nanoparticles; Oligodeoxyribonucleotides; Paclitaxel; Particle Size; Photoelectron Spectroscopy; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Static Electricity; Surface Properties; Tissue Distribution; Treatment Outcome | 2011 |
Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Endocytosis; Glioma; Hep G2 Cells; Humans; Low Density Lipoprotein Receptor-Related Protein-1; Male; Mice; Mice, Nude; Paclitaxel; Peptides; Phenotype; Receptors, LDL; RNA Interference; Tumor Microenvironment; Tumor Suppressor Proteins | 2011 |
Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Glioma; Humans; Liposomes; Mice; Mice, Inbred BALB C; Microscopy, Atomic Force; Paclitaxel; Peptides; TNF-Related Apoptosis-Inducing Ligand | 2012 |
Experimental study on biodegradable polymer-paclitaxel conjugate micelles for chemotherapy of C6 glioma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Body Weight; Brain Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Glioma; Injections, Intravenous; Magnetic Resonance Imaging; Micelles; Paclitaxel; Permeability; Polyethylene Glycols; Polymers; Rats; Rats, Wistar; Technology, Pharmaceutical; Time Factors; Tumor Burden | 2011 |
Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Chemical Phenomena; Drug Carriers; Drug Compounding; Erythrocytes; Glioma; Hemolysis; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Micelles; Paclitaxel; Polyesters; Rats; Rats, Sprague-Dawley; Survival Analysis; Tissue Distribution; Transferrin | 2012 |
Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy.
Topics: Animals; Blood-Brain Barrier; Cell Line; Cell Line, Tumor; Glioma; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Micelles; Models, Biological; Nanomedicine; Oligopeptides; Paclitaxel; Rats, Sprague-Dawley; Transferrin; Xenograft Model Antitumor Assays | 2012 |
Radiation necrosis of a high-grade glioma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Dacarbazine; Glioma; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Necrosis; Paclitaxel; Polyglutamic Acid; Temozolomide | 2012 |
TRAIL and paclitaxel synergize to kill U87 cells and U87-derived stem-like cells in vitro.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 8; Cell Line; Drug Synergism; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glioma; Humans; Neoplasm Proteins; Neoplastic Stem Cells; Paclitaxel; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation | 2012 |
A novel therapeutic system for malignant glioma: nanoformulation, pharmacokinetic, and anticancer properties of cell-nano-drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Glioma; Humans; Macrophages; Nanostructures; Paclitaxel | 2013 |
F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Glioma; Mice; Mice, Nude; Nanocapsules; Paclitaxel; Peptides; Peptides, Cyclic; Polyethylene Glycols; Rats; Treatment Outcome | 2013 |
Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model.
Topics: Analysis of Variance; Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Dacarbazine; Disease Models, Animal; Drug Delivery Systems; Drug Therapy, Combination; Female; Gels; Glioma; Humans; Neoplasm Transplantation; Paclitaxel; Rats; Rats, Inbred F344; Survival Analysis; Temozolomide | 2013 |
Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Emulsions; Glioma; Lethal Dose 50; Linoleic Acid; Mice; Nanocapsules; Paclitaxel; Treatment Outcome | 2012 |
Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dioxanes; Drug Carriers; Glioma; Humans; Integrins; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Polymers; Transcytosis | 2013 |
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Capillaries; Cells, Cultured; Cyclosporins; Glioblastoma; Glioma; Humans; Paclitaxel; Swine; Tumor Cells, Cultured | 2002 |
Interobserver variability in the radiological assessment of response to chemotherapy in glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Ependymoma; Female; Glioblastoma; Glioma; Humans; Image Enhancement; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Paclitaxel; Procarbazine; Sensitivity and Specificity; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2003 |
Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chromones; Cisplatin; Drug Synergism; Enzyme Inhibitors; Etoposide; Glioma; Humans; Microtubules; Morpholines; Paclitaxel; Phosphoinositide-3 Kinase Inhibitors; Tumor Cells, Cultured; Vincristine | 2003 |
Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy?
Topics: Administration, Topical; Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Chemotherapy, Adjuvant; Glioma; Hyperthermia, Induced; Laser Therapy; Neurosurgical Procedures; Paclitaxel; Permeability; Rats; Rats, Inbred F344 | 2003 |
Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies.
Topics: Animals; Biocompatible Materials; Blood-Brain Barrier; Cell Line, Tumor; Central Nervous System Neoplasms; Chromatography, High Pressure Liquid; Drug Delivery Systems; Glioma; Inflammation; Male; Microspheres; Paclitaxel; Proportional Hazards Models; Rats; Rats, Inbred F344; Time Factors | 2003 |
Fabrication of monodispersed Taxol-loaded particles using electrohydrodynamic atomization.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Buffers; Calorimetry, Differential Scanning; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Compounding; Electrochemistry; Glioma; Humans; Microscopy, Electron, Scanning; Paclitaxel; Particle Size; Solubility | 2005 |
PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors.
Topics: Androstadienes; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Glioma; Humans; Interferon-alpha; Kidney Neoplasms; Lung Neoplasms; Mice; Mice, Nude; Molecular Structure; Molecular Weight; Neoplasm Transplantation; Neoplasms; Paclitaxel; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2005 |
The brain slice chamber, a novel variation of the Boyden Chamber Assay, allows time-dependent quantification of glioma invasion into mammalian brain in vitro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Astrocytes; Brain Neoplasms; Coculture Techniques; Dose-Response Relationship, Drug; Extracellular Matrix; Frontal Lobe; Glioma; Neoplasm Invasiveness; Organ Culture Techniques; Paclitaxel; Parietal Lobe; Swine; Vincristine | 2005 |
Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Dialysis; Drug Compounding; Drug Delivery Systems; Electrochemistry; Excipients; Glioma; Humans; Injections; Injections, Intravenous; Lactic Acid; Microscopy, Electron, Scanning; Nanostructures; Paclitaxel; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2005 |
Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Brain Neoplasms; Calorimetry, Differential Scanning; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Diazonium Compounds; Electrochemistry; Farnesol; G2 Phase; Glioma; Humans; Microscopy, Electron, Scanning; Microspheres; Models, Statistical; Molecular Weight; Paclitaxel; Polymers; Solvents; Spectrometry, X-Ray Emission; Surface Properties; Temperature; Time Factors | 2006 |
Noscapine and diltiazem augment taxol and radiation-induced S-phase arrest and clonogenic death of C6 glioma in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Diltiazem; Drug Synergism; Glioma; Humans; Microscopy, Electron; Mitochondria; Noscapine; Paclitaxel; S Phase; Tumor Stem Cell Assay | 2006 |
Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Drug Synergism; Glioblastoma; Glioma; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Interferon-alpha; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Polyethylene Glycols; Transplantation, Heterologous | 2006 |
Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chromatography, Gel; Delayed-Action Preparations; Drug Compounding; Excipients; Glioma; Humans; Lactic Acid; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Spectrometry, X-Ray Emission | 2006 |
A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Capsules; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endocytosis; Glioma; Male; Nanostructures; Nitriles; Paclitaxel; Rats; Rats, Inbred F344; RNA, Messenger | 2006 |
In vitro drug response and molecular markers associated with drug resistance in malignant gliomas.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Brain Neoplasms; Camptothecin; Carmustine; Cisplatin; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioma; Glutathione S-Transferase pi; Humans; Immunohistochemistry; Irinotecan; Paclitaxel; Structure-Activity Relationship; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Vincristine | 2006 |
SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress.
Topics: Cell Line, Tumor; Chromosomal Instability; Chromosomes, Human; Glioma; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Mitosis; Nocodazole; Paclitaxel; Polyploidy; Sirtuin 2; Sirtuins; Stress, Physiological; Tubulin; Ultraviolet Rays; X-Rays | 2007 |
In vivo performance of implantable biodegradable preparations delivering Paclitaxel and Etanidazole for the treatment of glioma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Cell Line, Tumor; Drug Delivery Systems; Etanidazole; Glioma; Mice; Mice, Inbred BALB C; Mice, Nude; Microspheres; Neoplasm Transplantation; Paclitaxel; Radiation-Sensitizing Agents; Rats | 2007 |
The Coxsackie and adenovirus receptor binds microtubules and plays a role in cell migration.
Topics: Amino Acid Sequence; Cell Line, Tumor; Cell Movement; Coxsackie and Adenovirus Receptor-Like Membrane Protein; Dimerization; Glioma; Humans; Microtubules; Molecular Sequence Data; Paclitaxel; Protein Structure, Tertiary; Receptors, Virus; Tubulin | 2007 |
Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Calorimetry, Differential Scanning; Cell Survival; Chromatography, High Pressure Liquid; Coumarins; Drug Compounding; Fluorescent Dyes; Glioma; Humans; Lactic Acid; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanoparticles; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pressure; Tetrazolium Salts; Thiazoles | 2007 |
Initial Experience with a Novel Low-Dose Micro-CT System.
Topics: Animals; Coated Materials, Biocompatible; Contrast Media; Coronary Angiography; Coronary Restenosis; Equipment Design; Glioma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Iohexol; Iopamidol; Mice; Mice, Nude; Miniaturization; Muscle, Skeletal; Neoplasm Transplantation; Paclitaxel; Phantoms, Imaging; Radiation Dosage; Rats; Sensitivity and Specificity; Soft Tissue Neoplasms; Stents; Swine; Tomography Scanners, X-Ray Computed | 2007 |
Multiparameter noninvasive assessment of treatment susceptibility, drug target inhibition and tumor response guides cancer treatment.
Topics: Animals; Annexins; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Early Diagnosis; Female; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice; Mice, Inbred C57BL; Mice, Nude; Microscopy, Confocal; Microscopy, Fluorescence; Neoplasms; Paclitaxel; Predictive Value of Tests; Receptor, ErbB-2; Spectrometry, Fluorescence; Spectroscopy, Near-Infrared; Trastuzumab; Up-Regulation | 2007 |
Biodegradable films developed by electrospray deposition for sustained drug delivery.
Topics: Brain Neoplasms; Calorimetry, Differential Scanning; Drug Delivery Systems; Glioma; Humans; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Paclitaxel; Spectrometry, Mass, Electrospray Ionization; X-Ray Diffraction | 2008 |
Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Brain Neoplasms; Cell Line, Tumor; Cellular Senescence; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Silencing; Glioma; Humans; Methyltransferases; Paclitaxel; RNA, Messenger; Telomerase | 2008 |
Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epothilones; Female; Glioma; Magnetic Resonance Imaging; Mice; Mice, Nude; Microtubules; Neoplasm Proteins; Paclitaxel; Pancreatic Neoplasms; Rats; Rats, Inbred Lew; Tissue Distribution; Xenograft Model Antitumor Assays | 2008 |
Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Delivery Systems; Glioma; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Scanning; Paclitaxel; Rats | 2008 |
Distinct mode of microtubule-associated protein 2 expression in the neuroblastoma/glioma cell line 108CC15/NG108-15.
Topics: Animals; Antibodies, Monoclonal; Base Sequence; Blotting, Northern; Brain Neoplasms; Cell Division; Epitopes; Glioma; In Situ Hybridization; Mice; Microtubule-Associated Proteins; Molecular Sequence Data; Neuroblastoma; Paclitaxel; Polymerase Chain Reaction; Rats; RNA, Neoplasm; Tumor Cells, Cultured | 1993 |
Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors.
Topics: Adult; Aged; Animals; Brain; Brain Neoplasms; Female; Glioma; Humans; Infusions, Intravenous; Middle Aged; Paclitaxel; Rats; Rats, Inbred F344 | 1995 |
Paclitaxel (Taxol) concentrations in brain tumor tissue.
Topics: Adult; Blood-Brain Barrier; Brain; Brain Neoplasms; Glioma; Humans; Male; Paclitaxel; Pilot Projects; Tissue Distribution | 1994 |
Regulation of beta-adrenergic receptor mRNA in rat C6 glioma cells is sensitive to the state of microtubule assembly.
Topics: Animals; Binding Sites; Colchicine; Cyclic AMP; Dose-Response Relationship, Drug; Down-Regulation; Glioma; Homeostasis; Isoproterenol; Microtubules; Paclitaxel; Rats; Receptors, Adrenergic, beta; RNA, Messenger; Tumor Cells, Cultured | 1994 |
Cytotoxicity of taxol in vitro against human and rat malignant brain tumors.
Topics: Animals; Brain Neoplasms; Cerebellar Neoplasms; Glioma; Humans; Medulloblastoma; Paclitaxel; Rats; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1994 |
Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.
Topics: Animals; Biopolymers; Brain; Clinical Trials, Phase II as Topic; Decanoic Acids; Drug Implants; Glioma; Humans; Male; Paclitaxel; Polyesters; Rats; Rats, Inbred F344; Survival Analysis; Tissue Distribution | 1994 |
Estramustine: a novel radiation enhancer in human carcinoma cells.
Topics: Breast Neoplasms; Cell Cycle; Cell Survival; Colonic Neoplasms; Combined Modality Therapy; Estramustine; Female; Flow Cytometry; Glioma; HeLa Cells; Humans; Male; Microtubules; Neoplasms; Paclitaxel; Prostatic Neoplasms; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Vinblastine | 1994 |
Synthesis and accumulation of alphaB crystallin in C6 glioma cells is induced by agents that promote the disassembly of microtubules.
Topics: Animals; Aphidicolin; Colchicine; Crystallins; Culture Media, Serum-Free; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; Glioma; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Microtubules; Mitosis; Paclitaxel; Protein Kinase Inhibitors; Rats; Staurosporine; Tubulin; Tumor Cells, Cultured | 1996 |
Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Flow Cytometry; G1 Phase; G2 Phase; Glioma; Humans; Mitosis; Paclitaxel; Radiation-Sensitizing Agents; Time Factors; Tumor Cells, Cultured | 1997 |
Evaluation of lipid-coated microbubbles as a delivery vehicle for Taxol in brain tumor therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Capsules; Cell Division; Cell Survival; Drug Carriers; Glioma; Gliosarcoma; Humans; Liposomes; Neoplasm Transplantation; Paclitaxel; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1997 |
Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro.
Topics: Adult; Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Division; Cell Movement; Female; Flow Cytometry; Glioblastoma; Glioma; Glycerol; Humans; Microscopy, Confocal; Paclitaxel; Rats; Rats, Wistar; Solvents; Spheroids, Cellular; Tumor Cells, Cultured | 1997 |
Adenovirus-mediated p16 transfer to glioma cells induces G1 arrest and protects from paclitaxel and topotecan: implications for therapy.
Topics: Adenoviridae; Antineoplastic Agents; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p16; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; G1 Phase; Glioma; Humans; Paclitaxel; Recombinant Proteins; Time Factors; Topotecan; Transfection | 1998 |
Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Drug Synergism; Fas Ligand Protein; fas Receptor; G2 Phase; Glioma; Humans; Immunotherapy; Membrane Glycoproteins; Mitosis; Paclitaxel; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 1998 |
Role of microtubules in glucose uptake by C6 glioma cells.
Topics: Animals; Carbachol; Colchicine; Deoxyglucose; Dose-Response Relationship, Drug; Glioma; Glucose Transporter Type 1; Microtubules; Monosaccharide Transport Proteins; Paclitaxel; Rats; Transfection; Tubulin; Tumor Cells, Cultured; Vinblastine | 1998 |
Failure of taxol-based combination chemotherapy for malignant glioma cannot be overcome by G2/M checkpoint abrogators or altering the p53 status.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Caffeine; G2 Phase; Genes, p53; Glioma; Humans; Mitosis; Paclitaxel; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1999 |
Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Carmustine; Cell Death; Cell Division; Cisplatin; Clone Cells; Combined Modality Therapy; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Gene Expression Regulation, Neoplastic; Genes, Dominant; Glioma; Humans; In Vitro Techniques; Paclitaxel; Point Mutation; Radiotherapy; Teniposide; Topotecan; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine | 1999 |
Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival.
Topics: Animals; Antineoplastic Agents; Bradykinin; Brain Neoplasms; Carboplatin; Glioma; Infusions, Intravenous; Male; Paclitaxel; Platinum; Rats; Rats, Inbred F344 | 2000 |
Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Marrow Cells; Breast Neoplasms; Cancer Vaccines; Cell Membrane; Cisplatin; Cloning, Molecular; Female; Flow Cytometry; Glioma; Immunohistochemistry; Macrophage Colony-Stimulating Factor; Macrophages; Necrosis; Neoplasm Transplantation; Paclitaxel; Rats; Rats, Inbred F344; Retroviridae; Time Factors; Transduction, Genetic; Transfection; Tumor Cells, Cultured | 2001 |
Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Convection; Diffusion; Drug Delivery Systems; Glioma; Humans; Magnetic Resonance Imaging; Monitoring, Physiologic; Neoplasm Recurrence, Local; Paclitaxel; Water | 2001 |
A novel taxane active against an orthotopically growing human glioma xenograft.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Neoplasms; Bridged-Ring Compounds; Glioma; Humans; Indoles; Infusions, Intravenous; Mice; Mice, Nude; Paclitaxel; Taxoids; Transplantation, Heterologous | 2001 |
Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance.
Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphatases; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Carrier Proteins; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dacarbazine; DNA Repair Enzymes; DNA-Binding Proteins; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Glioma; Guanine; Humans; Mismatch Repair Endonuclease PMS2; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; O(6)-Methylguanine-DNA Methyltransferase; Paclitaxel; Phenotype; Proto-Oncogene Proteins c-bcl-2; Temozolomide; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Identification and spatial arrangement of high molecular weight proteins (Mr 300 000-330 000) co-assembling with microtubules from a cultured cell line (rat glioma C6).
Topics: Alkaloids; Animals; Calcium; Cell Line; Electrophoresis, Polyacrylamide Gel; Glioma; Intermediate Filament Proteins; Microscopy, Electron; Microtubule-Associated Proteins; Microtubules; Molecular Weight; Paclitaxel; Plectin; Protein Binding; Proteins; Rats | 1985 |